BIOCRYST PHARMACEUTICALS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2009 | — | $86.3M | $41.1M |
| FY2010 | — | $65.5M | $13.6M |
| FY2011 | — | $14.8M | $16.4M |
| FY2012 | — | $-454.0K | $20.9M |
| FY2013 | — | $-1.1M | $21.2M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2009 | — | $86.3M | $41.1M |
| FY2010 | — | $65.5M | $13.6M |
| FY2011 | — | $14.8M | $16.4M |
| FY2012 | — | $-454.0K | $20.9M |
| FY2013 | — | $-1.1M | $21.2M |